These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 16272330

  • 1. Combined effects of ATP on the therapeutic efficacy of antimicrobial drug regimens against Mycobacterium avium complex infection in mice and roles of cytosolic phospholipase A2-dependent mechanisms in the ATP-mediated potentiation of antimycobacterial host resistance.
    Tomioka H, Sano C, Sato K, Ogasawara K, Akaki T, Sano K, Cai SS, Shimizu T.
    J Immunol; 2005 Nov 15; 175(10):6741-9. PubMed ID: 16272330
    [Abstract] [Full Text] [Related]

  • 2. [Novel type of antimicrobial mechanism in host macrophages against mycobacterial infections].
    Shimizu T, Tomioka H.
    Nihon Hansenbyo Gakkai Zasshi; 2009 Sep 15; 78(3):283-91. PubMed ID: 19803380
    [Abstract] [Full Text] [Related]

  • 3. [Profiles of intracellular expression, distribution, and activation of phospholipase A2 in host macrophages infected with Mycobacterium avium complex].
    Sano C, Shimizu T, Tatano Y, Yasumoto K, Tomioka H.
    Kansenshogaku Zasshi; 2007 Nov 15; 81(6):695-9. PubMed ID: 18095468
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.
    Cai S, Sato K, Shimizu T, Yamabe S, Hiraki M, Sano C, Tomioka H.
    J Antimicrob Chemother; 2006 Jan 15; 57(1):85-93. PubMed ID: 16303883
    [Abstract] [Full Text] [Related]

  • 5. Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.
    Shimizu T, Tomioka H, Sato K, Sano C, Akaki T, Dekio S, Yamada Y, Kamei T, Shibata H, Higashi N.
    Antimicrob Agents Chemother; 1999 Mar 15; 43(3):514-9. PubMed ID: 10049260
    [Abstract] [Full Text] [Related]

  • 6. [Mechanism of bacterial regrowth at the sites of infection in Mycobacterium avium complex-infected mice during treatment with chemotherapeutic agents].
    Sato K, Tomioka H, Maw WW, Saito H.
    Kekkaku; 1995 Dec 15; 70(12):673-8. PubMed ID: 8551714
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
    Sato K, Tomioka H, Akaki T, Kawahara S.
    Int J Antimicrob Agents; 2000 Sep 15; 16(1):25-9. PubMed ID: 11185410
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
    Kohno Y, Ohno H, Miyazaki Y, Higashiyama Y, Yanagihara K, Hirakata Y, Fukushima K, Kohno S.
    Antimicrob Agents Chemother; 2007 Nov 15; 51(11):4071-6. PubMed ID: 17709469
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex.
    Tomioka H, Sano C, Sato K, Shimizu T.
    Int J Antimicrob Agents; 2002 Feb 15; 19(2):139-45. PubMed ID: 11850167
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prospects for development of new antituberculous drugs].
    Tomioka H.
    Kekkaku; 2002 Aug 15; 77(8):573-84. PubMed ID: 12235850
    [Abstract] [Full Text] [Related]

  • 13. Effects of picolinic acid on the antimicrobial functions of host macrophages against Mycobacterium avium complex.
    Tomioka H, Shimizu T, Tatano Y.
    Int J Antimicrob Agents; 2007 Apr 15; 29(4):460-4. PubMed ID: 17296287
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Present status and future prospects of chemotherapeutics for intractable infections due to Mycobacterium avium complex.
    Tomioka H.
    Curr Drug Discov Technol; 2004 Dec 15; 1(4):255-68. PubMed ID: 16472242
    [Abstract] [Full Text] [Related]

  • 17. Activity of picolinic acid in combination with the antiprotozoal drug quinacrine against Mycobacterium avium complex.
    Shimizu T, Tomioka H.
    Antimicrob Agents Chemother; 2006 Sep 15; 50(9):3186-8. PubMed ID: 16940126
    [Abstract] [Full Text] [Related]

  • 18. Anti-Mycobacterium avium complex activity of clarithromycin, rifampin, rifabutin, and ethambutol in combination with adenosine 5'-triphosphate.
    Tatano Y, Yamabe S, Sano C, Tomioka H.
    Diagn Microbiol Infect Dis; 2017 Jul 15; 88(3):241-246. PubMed ID: 28511780
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages.
    Sato K, Akaki T, Tomioka H.
    J Antimicrob Chemother; 1998 Jan 15; 41(1):77-83. PubMed ID: 9511040
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.